5Voog E,Morschhauser F,Solal-Celigny P,et al.Neutropenia in patients treated with rituximab[J].N Engl J Med,2003,348:2691-2694.
6Tournamille JF,Rigal-Huguet F,Pathak A,et al.Cardiac effects of cytokines produced after rituximab infusion[J].Bull Cancer,2005,92(9):769-771.
7Kanamori H,Tsutsumi Y,Mori A,et al.Delayed reduction in left ventricular function following treatment of non Hodgkin′s lymphoma with chemotherapy and rituximab,unrelated to acute infusion reaction[J].Cardiology,2006,105(3):184-187.
6Landis SH, Murray T, Bolden S, et al. Cancer statistics, 1998[J]. CA Cancer J Clin, 1998,48( 1 ) : 6 -29.
7Marcus R. Current treatment options in aggressive lymphoma [ J]. Leuk Lymphoma,2003,44 Suppl 4 : S15 -27.
8Maloney DG, Smith B, Rose A. Rituximab: mechanism of action and resistance [ J ]. Semin Oncol ,2002,29 ( 1 Suppl 2) :2 - 9.
9Deans JP, Li H, Polyak MJ. CD20-mediated apoptosis: Signaling through lipid rufts[J]. Immunology. 2002,107(2) : 176-182.
10Shan D, Ledbetter JA, Press OW. Signaling events involved in anti-CD20-induced apoptosis of malignant human B cells [J]. Cancer Immunol Immunother, 2000,48 (12) : 673-683.